Skip to content
Home/Companies/Biotech/Moleculent

Moleculent

Biotech·Sweden·Active·2yr hold
Entry
2024
Hold
2yr
Status
Active

Who owns Moleculent?

Moleculent is currently owned by Eir Ventures through Eir Ventures I (2020 vintage), since 2024.

Hand-verified · updated 2026-08-17

Eir Ventures
Investor
Eir Ventures
Eir Ventures I · 2020 · Life Sciences VC

Key facts

HQSweden
SectorBiotech
StatusActive

More from Eir Ventures I

Other portfolio companies in the same fund.

Purpose Pharma
Active
PharmaSweden· 2024
Dania Tx
Active
BiotechDenmark· 2023
GutCRINE
Active
BiotechDenmark· 2023
RAPP
Active
HealthTechSweden· 2023
Scenic Biotech
Scenic Biotech
Active
BiotechNetherlands· 2023
Attgeno
Active
BiotechSweden· 2022

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Moleculent

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Moleculent?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Moleculent.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyers and MOIC on realized deals (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue